D

DalCor Pharmaceuticals

6 employees

DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits

Basic info

Industry

pharmaceutical manufacturing

Sectors

Health Care
Genetics
Medical
Pharmaceutical
Precision Medicine and Cardiovascular

Date founded

2015

Funding rounds raised

Total raised

$100M

from 4 investors over 4 rounds

D

DalCor Pharmaceuticals raised $80M on September 13, 2023

Investors: T&B Pharma Consultoria - GMP and Aquavida

D

DalCor Pharmaceuticals raised $100M on April 18, 2016

Investors: Sanderling Ventures and Caisse de dépôt et placement du Québec (CDPQ)

FAQ